Chuck Ence - Dec 16, 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
CA and Compliance Officer
Signature
/s/ Chuck Ence
Stock symbol
RLMD
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/20/2022, 06:30 PM
Previous filing
Dec 21, 2021
Next filing
May 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Other -200K -100% 0 Dec 16, 2022 Common stock 200K $19.03 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated.
F2 Not applicable.
F3 Original expiration date.